97
Views
1
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial

, , , &
Pages 111-118 | Published online: 10 Jan 2014

References

  • International Diabetes Federation. Diabetes Atlas (3rd Edition). Brussels, Belgium (2006).
  • Woodward M, Zhang X, Barzi F et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia–Pacific region. Diabetes Care26, 360–366 (2003).
  • Adler AI, Stevens RJ, Manley SE et al. Development and progression of nephropathy in Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int.63(1), 225–232 (2003).
  • Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): prospective observational study. BMJ321(7258), 405–412 (2000).
  • HOPE (Heart Outcomes Prevention Evaluation) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N. Engl. J. Med.342, 145–153 (2000).
  • Tuomilehto J, Rastenyte D, Birkenhager WH et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N. Engl. J. Med.340(9), 677–684 (1999).
  • Kloner RA, Neutel J, Roth EM et al. Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the amlodipine diabetic hypertension efficacy response evaluation trial. Ann. Pharmacother.42(11), 1552–1562 (2008).
  • United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38. BMJ317, 703–713 (1998).
  • Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet351, 1755–1762 (1998).
  • Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet355, 253–258 (2000).
  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet352, 837–853 (1998).
  • ADVANCE Collaborative Group. Study rationale and design of ADVANCE: action in diabetes and vascular disease – preterax and Diamicron MR controlled evaluation. Diabetologia44(9), 1118–1120 (2001).
  • ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with Type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet370(9590), 829–840 (2007).
  • The Advance Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with Type 2 diabetes. N. Engl. J. Med.358(24), 2560–2572 (2008).
  • Chalmers J, Joshi R, Kengne AP et al. Efficacy and safety of fixed combination of perindopril and indapamide in Type 2 diabetes: results from ADVANCE in context of available evidence. J. Hypertens.26(Suppl. 3), S21–S27 (2008).
  • Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet362(9395), 1527–1535 (2003).
  • The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in Type 2 diabetes. N. Engl. J. Med.358(24), 2545–2559 (2008).
  • Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in Type 2 diabetes. N. Engl. J. Med.359(15), 1577–1589 (2008).
  • Chalmers J, Cooper ME. UKPDS and the legacy effect. NEJM359(15), 1618–1620 (2008).
  • Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with Type 2 diabetes. N. Engl. J. Med.360, 129–139 (2009).
  • Holman RR, Paul SK, Bethel MA, Neil HAW, Matthews DR. Long-term follow-up after tight control of blood pressure in Type 2 diabetes. N. Engl. J. Med.359(15), 1565–1576 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.